ZYNLONTA 10 mg/2mL
loncastuximab tesirine · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ADC Therapeutics America, Inc.
Zynlonta is a prescription injection used to treat a type of lymphoma called diffuse large B-cell lymphoma in patients who have already received other treatments. It is given as an intravenous infusion.
Key Facts
- Brand Name
- ZYNLONTA
- Generic Name
- loncastuximab tesirine
- NDC Code (Product)
79952-110- Manufacturer
- ADC Therapeutics America, Inc.
- Strength
- 10 mg/2mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761196
- Marketing Start
- 04/30/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is ZYNLONTA used for?
Zynlonta is a prescription injection used to treat a type of lymphoma called diffuse large B-cell lymphoma in patients who have already received other treatments. It is given as an intravenous infusion.
Is ZYNLONTA a controlled substance?
ZYNLONTA is not classified as a controlled substance by the DEA.
What is the generic name for ZYNLONTA?
The generic name for ZYNLONTA is loncastuximab tesirine. There are no other listed brand versions of loncastuximab tesirine.
What is the NDC code for ZYNLONTA 10 mg/2mL?
The NDC (National Drug Code) for ZYNLONTA 10 mg/2mL is 79952-110, listed by ADC Therapeutics America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)